ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01281943
Recruitment Status : Withdrawn (Doxil Shortage)
First Posted : January 24, 2011
Last Update Posted : July 4, 2013
Sponsor:
Information provided by (Responsible Party):
Washington University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : July 2012
  Estimated Study Completion Date : May 2014